Search results
Results from the WOW.Com Content Network
Benign prostatic hyperplasia ( BPH ), also called prostate enlargement, is a noncancerous increase in size of the prostate gland. [ 1] Symptoms may include frequent urination, trouble starting to urinate, weak stream, inability to urinate, or loss of bladder control. [ 1] Complications can include urinary tract infections, bladder stones, and ...
The International Prostate Symptom Score (IPSS) is an eight-question written screening tool used to screen for, rapidly diagnose, track the symptoms of, and suggest management of the lower urinary tract symptoms of benign prostatic hyperplasia (BPH). It contains seven questions related to symptoms related to BPH and one question related to the ...
Tamsulosin. Tamsulosin, sold under the brand name Flomax among others, is a medication used to treat symptomatic benign prostatic hyperplasia (BPH) and chronic prostatitis and to help with the passage of kidney stones. [ 6][ 7][ 8] The evidence for benefit with a kidney stone is better when the stone is larger. [ 8] Tamsulosin is taken by mouth.
Urology. [ edit on Wikidata] A prostatic stent is a stent used to keep open the male urethra and allow the passing of urine in cases of prostatic obstruction and lower urinary tract symptoms (LUTS). Prostatic obstruction [ 1] is a common condition with a variety of causes. Benign prostatic hyperplasia (BPH) is the most common cause, [ 2] but ...
Prostatic artery embolization (PAE, or prostate artery embolisation) is a non-surgical technique for treatment of benign prostatic hypertrophy (BPH). [1]The procedure involves blocking the blood flow of small branches of the prostatic arteries using microparticles injected via a small catheter, [2] to decrease the size of the prostate gland to reduce lower urinary tract symptoms.
Invasive therapies. There are two invasive surgical procedures done for BPH: Transurethral resection of the prostate (TURP): In general prior to emergence of laser technologies, TURP had been considered the gold standard of prostate interventions for people who require a procedure. This involves removing (part of) the prostate by inserting a ...
Around one third of men will develop urinary tract (outflow) symptoms, of which the principal underlying cause is benign prostatic hyperplasia. [25] Once symptoms arise, their progress is variable and unpredictable with about one third of patients improving, one third remaining stable and one third deteriorating. [citation needed]
Silodosin, sold under the brand name Urief among others, is a medication for the symptomatic treatment of benign prostatic hyperplasia. [ 4][ 5] It acts as an alpha-1 adrenergic receptor antagonist. [ 4][ 5] The most common side effect is a reduction in the amount of semen released during ejaculation. [ 5]